20/20 Biolabs (AIDX) vs Intelligent Bio Solutions (INBS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Intelligent Bio Solutions is the larger company by market cap ($5.2 million vs $5.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AIDX | INBS |
|---|---|---|
| Share price | $0.3878 | $1.58 |
| Market cap | $4.95M | $5.24M |
| 1-day change | +2.44% | +0.64% |
| Forward P/E | — | 4.51 |
| EPS (TTM) | $-0.75 | $-8.44 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $50.00 | $24.90 |
| 52-week low | $0.33 | $1.52 |
| Distance from 52-week high | -99.22% | -93.65% |
| Analyst consensus | none | none |
| Avg. price target upside | +1189.32% | +659.49% |
| Average volume | 90.86K | 160.86K |
| Shares outstanding | 12.77M | 3.32M |
| Employees | 4 | 59 |
| Sector | Health Care | Health Care |
| Industry | Precision Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About 20/20 Biolabs
AIDX stock →20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases.
Health Care · Precision Instruments · 4 employees
About Intelligent Bio Solutions
INBS stock →Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform.
Health Care · Medical/Dental Instruments · 59 employees
AIDX vs INBS FAQ
Which is bigger, 20/20 Biolabs or Intelligent Bio Solutions?
Intelligent Bio Solutions (INBS) is larger, with a market capitalization of $5.24M compared with $4.95M for 20/20 Biolabs (AIDX).
Are 20/20 Biolabs and Intelligent Bio Solutions in the same industry?
Both are in the Health Care sector, but in different industries: Precision Instruments for 20/20 Biolabs and Medical/Dental Instruments for Intelligent Bio Solutions.